BBH.L

BB Healthcare Trust (Red)
Bellevue Healthcare - Compliance with Market Abuse Regulation
6th February 2025, 15:56
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2386W
Bellevue Healthcare Trust PLC
06 February 2025
 

 

Bellevue Healthcare Trust plc

 

Compliance with Market Abuse Regulation

 

Bellevue Healthcare Trust plc (the "Company") announces that it is satisfied that all inside information which the Directors and the Company may have to the date of this announcement has previously been notified to a regulatory information service.

 

The Company is therefore not prohibited from repurchasing its own securities, or issuing new securities, during the closed period which ends on the date of the announcement of the Annual Financial Report for the year ended 30 November 2024.

 

The Company's LEI is: 213800HQ3J3H9YF2UI82

 

Enquiries:

 

Company Secretary                020 3697 5772

NSM Funds (UK) Limited

 

6 February 2025

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CMCUPUWAPUPAGAQ]]>
TwitterFacebookLinkedIn